Busch, A.G
Its argument is that stacking two agents from the same class without human trial evidence introduces the potential for cumulative adverse effects, and it names severe nausea, dehydration, and metabolic complications as the specific concerns
Improved Metabolic Markers Some patients experience lower blood pressure, reduced cholesterol levels, and improved blood sugar control
Haslerud, S., Magnussen, L
Establishing Safe Minimum Caloric and Protein Targets During GLP-1 Use Most healthcare providers recommend a minimum intake of 1,2001,500 calories daily for women and 1,5001,800 for men while using semaglutide, assuming moderate activity
(Editado en espaol por Carlos Serrano)